Sol-Gel Technologies Ltd

NASDAQ:SLGL   3:59:44 PM EDT
9.41
-0.12 (-1.26%)
Products

Sol-Gel Technologies Announces FDA Acceptance For Filing Of New Drug Application For Epsolay

Published: 09/10/2020 20:18 GMT
Sol-Gel Technologies Ltd (SLGL) - Sol-gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea.
Sol Gel Technologies Ltd - PDUFA Goal Date Set for April 26, 2021.